Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on: February 03,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on:February 03,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Updated on: June 04,2024

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Updated on:June 04,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on: March 20,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on:March 20,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on: May 11,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on:May 11,2024

Researchers report method to determine the absolute dose for new radiotherapy cancer treatment technique

by National Physical LaboratoryExperimental setup mounted on the patient couch and radiograph of the NPL PSPC. (a) (1) Gantry, (2) NPL PSPC, (3) measurement instrumentation for the NPL PSPC, (4)

Updated on: February 01,2024

Researchers report method to determine the absolute dose for new radiotherapy cancer treatment technique

by National Physical LaboratoryExperimental setup mounted on the patient couch and radiograph of the NPL PSPC. (a) (1) Gantry, (2) NPL PSPC, (3) measurement instrumentation for the NPL PSPC, (4)

Updated on:February 01,2024

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on: July 30,2024

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on:July 30,2024

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on: February 03,2024

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on:February 03,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on: May 05,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on:May 05,2024

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on: November 11,2024

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on:November 11,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on: January 11,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on:January 11,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on: January 29,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on:January 29,2024